Abstracts

Cotrimoxazole and Reduced Infectious Morbidity in HIV-Exposed Uninfected Infants

Diarrhea and respiratory infections are among the leading causes of global morbidity and mortality in young children, with HIV-exposed infants at increased risk. Cotrimoxazole prophylaxis (CPT) may reduce such morbidity in the growing population of HIV-exposed, uninfected infants. A cohort study was conducted using data from the Breastfeeding, Antiretrovirals and Nutrition (BAN) clinical trial (conducted…

HIV-Exposed Children Account for More Than Half of 24-Month Mortality in Botswana

The relative contribution of HIV-exposure and HIV-infection to childhood mortality in a programmatic setting with widespread antiretroviral treatment (ART) use in pregnancy is not well described. From March 2012-March 2013, women and their children were enrolled within 48 hours of delivery in 5 geographically diverse government-run postpartum wards in Botswana.  Maternal obstetric and medical history,…

Mortality Risk Associated With Preterm and SGA Stratified by Maternal HIV Status

Preterm and small-for-gestational-age (SGA), two distinct biological processes leading to low birth weight (LBW), are associated with increased risk of mortality during infancy. The risk of mortality due to these conditions among vulnerable populations such as HIV exposed infants are yet to be estimated. Using the recent intergrowth standard to define SGA, we have evaluated the…

Viraemic Episodes Occur Frequently in Postpartum South African Women on ART

With growing numbers of pregnant women starting antiretroviral (ART) there are significant concerns regarding adherence, especially during the postpartum (PP) period. Viral load (VL) monitoring for pregnant and PP women is promoted in international guidelines to identify nonadherence and treatment failure, but little is known about the frequency and magnitude of elevated VL in this…

Viral Suppression and Retention 2-5 Years After ART Initiation in Pregnancy in Uganda

Recent studies have demonstrated that up to 40% of women are lost to follow-up after initiating antiretroviral therapy (ART) during pregnancy in Option B+ programs. Data are limited on long-term virologic outcomes and retention in care, particularly after cessation of breastfeeding. We evaluated retention in care and viral suppression (VS) 2-5 years postpartum among previously…